KITS, MOLECULAR DIAGNOSTICS

Local Distributor Manufacturer Model Number (if applicable) Specifications
BIO-STRATEGY LIMITED BIO-STRATEGY LIMITED NANOSTRING TECHNOLOGIES
Prosigna™ Breast Cancer Prognostic Gene Signature Assay The Prosigna™ Breast Cancer Prognostic Gene Signature Assay is an in vitro diagnostic assay which uses the gene expression profile of cells found in breast cancer tissue to assess a patient’s risk of distant recurrence. The assay measures the gene expression profile using RNA extracted from Formalin-Fixed, Paraffin-Embedded (FFPE) breast tumor tissue. The gene expression data are weighted together with clinical variables to generate both a subtype (luminal A, luminal B, HER2-enriched, or basal-like) and a score indicative of the probability of distant recurrence of disease. The assay is performed on the NanoString nCounter® Analysis System using FFPE breast tumor tissue previously diagnosed as invasive breast carcinoma.
GLOBAL SCIENCE - a VWR company GLOBAL SCIENCE - a VWR company AUSDIAGNOSTICS
Easy-plex, High-Plex Automated system with kits for real-time multiplex PCR detection of pathogens for IVD diagnostics, veterinary and food applications.
NGAIO DIAGNOSTICS GREAT BASIN SCIENTIFIC Multiplexes up to 64 distinct targets in a single assay for more answers. Rapid results in less than an hour depending on the target of interest. On-demand testing; no batching of tests that delays results. Fully automated with no more than two-to-three h
NGAIO DIAGNOSTICS INTRON BIOTECHNOLOGY A range of kits for animal and plant diagnostics